✦ LIBER ✦

Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor

✍ Scribed by Giordanetto, Fabrizio; Wållberg, Andreas; Knerr, Laurent; Selmi, Nidhal; Ullah, Victoria; Thorstensson, Fredrik; Lindelöf, Åsa; Karlsson, Staffan; Nikitidis, Grigorios; Llinas, Antonio; Wang, Qing-Dong; Lindqvist, Anders; Högberg, Ågot; Lindhardt, Emma; Åstrand, Annika; Duker, Göran

Book ID: 120600917
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 1003 KB
Volume: 23
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.10.140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of N-(1-adamantyl)-2-(4-alkylp

Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors

✍ Fabrizio Giordanetto; Laurent Knerr; Nidhal Selmi; Antonio Llinàs; Anders Lindqv 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 851 KB

The Discovery of N -((2 H -Tetrazol-5-yl

The Discovery of N -((2 H -Tetrazol-5-yl)methyl)-4-(( R )-1-((5 r ,8 R )-8-( tert -butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist

✍ DeMong, Duane; Dai, Xing; Hwa, Joyce; Miller, Michael; Lin, Sue-Ing; Kang, Ling; 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 529 KB

Novel Inhibitor of p38 MAP Kinase as an

Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug: Discovery of N -[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent

✍ Miwatashi, Seiji; Arikawa, Yasuyoshi; Kotani, Etsuo; Miyamoto, Maki; Naruo, Ken- 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 382 KB

Discovery of 5-(2-amino-[1,2,4]triazolo[

Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease

✍ Mihiro Sunose; Kathryn Bell; Katie Ellard; Giovanna Bergamini; Gitte Neubauer; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 604 KB

ChemInform Abstract: Discovery of 5-(2-A

ChemInform Abstract: Discovery of 5-(2-Amino-[1,2,4]triazolo [1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease.

✍ Sunose, Mihiro; Bell, Kathryn; Ellard, Katie; Bergamini, Giovanna; Neubauer, Git 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 23 KB

Piperazine-Based CCR5 Antagonists as HIV

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1( R )-4-(trifluoromethyl)phenyl}ethyl-3( S )-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist

✍ Tagat, Jayaram R.; McCombie, Stuart W.; Nazareno, Dennis; Labroli, Marc A.; Xiao 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 78 KB